Les Sulewski
Stock Analyst at Truist Securities
(1.04)
# 3,866
Out of 5,124 analysts
16
Total ratings
50%
Success rate
-13.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $36 → $38 | $34.80 | +9.20% | 2 | Jan 29, 2026 | |
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $5.73 | +39.62% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $20.36 | +37.52% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $46.90 | +2.35% | 3 | Nov 7, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $14.77 | -18.75% | 3 | Oct 2, 2024 |
Teva Pharmaceutical Industries
Jan 29, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $34.80
Upside: +9.20%
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $5.73
Upside: +39.62%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $20.36
Upside: +37.52%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $46.90
Upside: +2.35%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $14.77
Upside: -18.75%